Skip to content

Invesco

US · IVZ #1217 by market cap Listed 1970
26.51 -1.26 -4.54%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 34 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
97.89% -0.09pp
Institutions
831 +34
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund59.52%
Private Company20.29%
Hedge Fund10.79%
Public Company3.76%
Government Pension Fund1.57%
Sovereign Wealth Fund1.19%
Individual/Insider0.69%
Family Office/Trust0.31%
Insurance Company0.29%
Other1.59%

Top holders as of 2026-02-17

Massachusetts Mutual Life Insurance Company 18.52% · 81.41M sh
BlackRock 8.81% · 38.71M sh
Vanguard Capital Management, LLC 6.95% · 30.57M sh
Dimensional Fund Advisors 4.74% · 20.82M sh
Vanguard Portfolio Management, LLC 4.20% · 18.46M sh
State Street Global Advisors 3.82% · 16.79M sh
Millennium Management LLC 3.57% · 15.69M sh
Geode Capital Management, LLC 2.82% · 12.40M sh
AQR Capital Management 2.80% · 12.33M sh
T. Rowe Price Group, Inc. 2.42% · 10.62M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 21 sells

NameRoleStake
Massachusetts Mutual Life Insurance Company -- 18.52%
Andrew Tak Lo Senior MD & Head of Asia Pacific 0.18%
Andrew Schlossberg Chief Executive Officer 0.17%
Laura Dukes Senior MD & CFO 0.06%
Tony Wong Senior MD & Co-Head of Investments 0.03%
Jeffrey Kupor Senior MD & General Counsel 0.03%
G. Wagoner Chair of the Board 0.03%
Sarah Beshar Independent Non-Executive Director 0.03%
Phoebe Wood Independent Non-Executive Director 0.02%
Nigel Sheinwald Independent Non-Executive Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-15 Shannon Johnston Senior MD & Chief Information and Operations Officer Derivative Exercise and Sale -12,526 $28.20
2026-10-15 Shannon Johnston Senior MD & Chief Information and Operations Officer Derivative Exercise and Retained +15,723 --
2026-09-10 Phoebe Wood Independent Non-Executive Director Open Market Disposition -3,000 $32.44
2026-09-08 Andrew Tak Lo Senior MD & Head of Asia Pacific Open Market Disposition -143,370 $32.20–32.85
2026-09-08 Andrew Tak Lo Senior MD & Head of Asia Pacific Intent to Sell (Form 144) -100,840 $32.20
2026-09-08 Stephanie Butcher Senior MD & Co-Head of Investment Open Market Disposition -45,095 $32.28
2026-09-07 Andrew Tak Lo Senior MD & Head of Asia Pacific Intent to Sell (Form 144) -42,530 $32.85
2026-09-03 Laura Dukes Senior MD & CFO Other Disposition -7,600 --
2026-09-03 Laura Dukes Senior MD & CFO Open Market Disposition -31,075 $33.16
2026-08-30 Stephanie Butcher Senior MD & Co-Head of Investment Derivative Exercise and Sale -30,760 $32.78
2026-08-30 Stephanie Butcher Senior MD & Co-Head of Investment Derivative Exercise and Retained +34,682 --
2026-08-30 Douglas Sharp Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK Derivative Exercise and Sale -22,213 $32.78
2026-08-30 Douglas Sharp Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK Derivative Exercise and Retained +48,272 --
2026-07-01 Jeffrey Kupor Senior MD & General Counsel Sale to Issuer -26,002 $27.01
2026-07-01 Andrew Tak Lo Senior MD & Head of Asia Pacific Derivative Exercise and Retained +116,754 --
2026-07-01 Andrew Schlossberg Chief Executive Officer Sale to Issuer -156,007 $27.01
2026-07-01 Laura Dukes Senior MD & CFO Sale to Issuer -52,003 $27.01
2026-05-14 G. Wagoner Chair of the Board Other Acquisition +8,112 --
2026-05-14 Thomas Finke Independent Non-Executive Director Other Acquisition +8,112 --
2026-05-14 William Glavin Independent Non-Executive Director Other Acquisition +8,112 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Invesco discussion 0 comments

Add a comment